Cervical cancer – the fourth most common cancer in women – claims over 350 000 lives each year, yet it is a disease that we have the tools to eliminate.
To help fill this gap, Kaushik’s team designed a pilot study (ClinicalTrials.gov NCT02620033) to evaluate a yoga therapy program for men newly diagnosed with localized prostate cancer who were ...
ADT is a type of hormone therapy that is commonly given alongside radiation to slow the growth of prostate cancer by lowering testosterone. While effective at controlling the disease, long-term ADT ...
Liquid biopsies can identify cancer-related biomarkers in body fluids like blood, saliva, or urine. This allows for cancer detection at earlier stages than traditional screening methods and may lead ...
Miracle Mineral Solution and other products containing sodium chlorite—an oxidizer chemically similar to household bleach—can cause severe vomiting and diarrhea and is not effective as a treatment for ...
U.S. Cancer Registries, Constrained by Trump Policies, to Recognize Only ‘Male’ or ‘Female’ Patients
Scientists and advocates for trans rights say the change will make it much harder to understand cancer diagnoses and trends among the trans population.
“The broad support for team-based models using community health workers was surprising, given the increasing reliance on technology to deliver supportive cancer care,” stated senior author Manali ...
Addyi (flibanserin), a drug that helps balance chemical messengers in the brain, led to improvements in sexual desire (libido), arousal and satisfaction, less pain and better health-related quality of ...
The Three’s Company actress and ThighMaster creator first went public with her breast cancer diagnosis in 2000. She had a lumpectomy and radiation but declined chemotherapy. In fact, in 2009, she ...
University of Colorado Cancer Center’s Laura Graham, MD, explains that such symptoms as weight loss, sleeplessness, and changes in bathroom habits could be early warning signs. November 18, 2025 • By ...
In a clinical trial of previously treated patients, a majority of those who responded to Hyrnuo had delayed disease progression for at least six months.
Combination of radiation, chemotherapy and immunotherapy can shrink tumors and allow surgery, with much better survival rate than non-surgical treatment alone.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results